Tang Su S - OmicsDI

Show results for

Unknown (1087)
Transcriptomics (30)
Proteomics (21)
Genomics (9)
Metabolomics (7)

Organisms

Homo sapiens (34)
Mus musculus (14)
Rattus norvegicus (2)
Drosophila melanogaster (2)
Acipenser transmontanus (1)
Picea engelmannii x Picea glauca (1)
Medicago truncatula (1)
Oryza sativa Japonica Group (1)
Campylobacter jejuni (1)
Severe acute respiratory syndrome coronavirus 2 (1)
Dendrobium huoshanense (1)

Repository

biostudies-arrayexpress (37)
iProX (10)
pride (8)
MetaboLights (7)
MassIVE (3)
EGA (2)

Tissue

Cell culture (3)
Epithelial cell (3)
Blood plasma (1)
Gastric epithelial cell (1)
Oral squamous cell carcinoma cell (1)
Permanent cell line cell (1)
Whole body (1)

Disease

Diffuse gastric cancer (1)
Lung adenocarcinoma (1)
Lung cancer (1)
Wounds and Injuries (1)

Technology Type

Mass Spectrometry (8)
Mass spectrometry (7)
Shotgun proteomics (4)
Bottom-up proteomics (2)
Affinity purification coupled with mass spectrometry proteomics (1)
RNA mass spectrometry (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (4)
Orbitrap Fusion Lumos (2)
Liquid Chromatography MS - positive - reverse phase (2)
Illumina HiSeq 1500 (1)
Illumina NovaSeq 6000 (1)
LTQ XL (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (1)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (1)
Liquid Chromatography MS - negative - HILIC (1)
Liquid Chromatography MS - positive - hilic (1)
Q Exactive (1)

Publication Date

2012 (7)
2010 (7)
2025 (6)
2013 (6)
2015 (5)
2024 (5)
2023 (5)
2016 (4)
2014 (4)
2026 (3)
2020 (3)
2021 (3)
2011 (2)
2007 (2)
2019 (1)
2017 (1)
2022 (1)

CHEBI ID

CHEBI:16359 (3)
CHEBI:16525 (3)
CHEBI:28834 (3)
CHEBI:116314 (2)
CHEBI:133028 (2)
CHEBI:133077 (2)
CHEBI:133176 (2)
CHEBI:145096 (2)
CHEBI:15354 (2)
CHEBI:15401 (2)
CHEBI:15676 (2)
CHEBI:15728 (2)
CHEBI:15741 (2)
CHEBI:15756 (2)
CHEBI:15843 (2)
CHEBI:15864 (2)
CHEBI:15956 (2)
CHEBI:16027 (2)
CHEBI:16040 (2)
CHEBI:16235 (2)
CHEBI:16238 (2)
CHEBI:16243 (2)
CHEBI:16393 (2)
CHEBI:16473 (2)
CHEBI:16547 (2)
CHEBI:16566 (2)
CHEBI:16688 (2)
CHEBI:16695 (2)
CHEBI:16704 (2)
CHEBI:16708 (2)

Metabolite Name

Caffeic acid (2)
Cholic acid (2)
Deoxycholic acid (2)
Luteolin (2)
Neoquassin (2)
Sinapic acid (2)
()-3-Hydroxybutyric acid (1)
()-Enterolactone (1)
(+)-7-epi--9,10-dihydrojasmonic acid (1)
(+)-8'-hydroxyabscisic acid (1)
(+)-Catechin (1)
(+)-Galeon (1)
(+)-Gallocatechin (1)
(+)-abscisic acid beta-D-glucopyranosyl ester (1)
(+)-subersic acid (1)
(+/-)-Ethyl 3-acetoxy-2-methylbutyrate (1)
(+/-)5,6-EpETrE (1)
(+/-)8,9-EpETrE (1)
(-)-11-hydroxy-9,10-dihydrojasmonic acid (1)
(-)-11-hydroxy-9,10-dihydrojasmonic acid 11-beta-D-glucoside (1)
(-)-12-hydroxy-9,10-dihydrojasmonic acid (1)
(-)-5,7-Dihydroxy-3-(4-hydroxybenzyl)-4-chromanone (1)
(-)-8-hydroxy-11E,17-octadecadien-9-ynoic acid (1)
(-)-Epicatechin (1)
(-)-Linderol A (1)
(-)-Salvisyriacolide (1)
(-)-Sativan (1)
(1(10)E,4E,6a,8b)-8-Angeloyloxy-14-oxo-1(10),4,11(13)-germacratrien-12,6-olide (1)
(1(10)E,4a,5E)-1(10),5-Germacradiene-12-acetoxy-4,11-diol (1)
(10betaH,11xi)-11-Hydroxy-13-nor-6-eremophilen-8-one (1)

Study type

Transcription profiling by array (15)
RNA-seq of coding RNA (10)
ChIP-seq (3)
Methylation profiling by high throughput sequencing (3)
Other (2)
ChIP-chip by tiling array (1)
RNAi profiling by array (1)
Comparative genomic hybridization by array (1)
DNA-seq (1)

Release Date

2025 (183)
2022 (172)
2024 (140)
2023 (136)
2021 (104)
2020 (78)
2018 (58)
2019 (48)
2016 (35)
2026 (32)
2017 (27)
2015 (23)
2014 (21)
2012 (18)
2013 (17)
2010 (14)
2011 (6)
2009 (4)
2008 (4)
2007 (2)
2006 (1)
2005 (1)

Lab affiliation

Anhui University of Traditional Chinese Medicine (1)
Bengbu medical college (1)
Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, United States (1)
Department of Clinical Laboratory, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China. (1)
Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA (1)
Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. (1)
Guangzhou Medical University (1)
Institute of Molecular and Cellular Biology, Department of Life Science, National Taiwan University, Taipei, Taiwan (1)

Previous page
1 / 116
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 116
Next page

Sort by:

Relevance

Page size

Gluconeogenic enzyme PCK1 supports S-adenosylmethionine biosynthesis and H3K9me3 to suppress HCC progression

Deciphering the crosstalk between metabolic reprogramming and epigenetic regulation is a promising strategy for cancer therapy. In this study, we discovered that the gluconeogenic enzyme PCK1 fuels the generation of S-adenosylmethionine (SAM) through the serine synthesis pathway. The methyltransfera...

2025-08-09 | MTBLS7651 | MetaboLights

Transcriptomic responses to cold stress in Dendrobium huoshanense C.Z. Tang et S.J. Cheng.

Not available

S-EPMC10754796 | biostudies-literature

REMUS: a tool for identification of unique peptide segments as epitopes.

Not available

S-EPMC1538771 | biostudies-literature

Effect of Kami Guibi-tang (KGT) in elderly subjects with insomnia: a study protocol from a single center, randomized, double-blind, placebo-controlled trial.

Not available

S-EPMC10594819 | biostudies-literature

Integrated 16S rRNA sequencing and nontargeted metabolomics analysis to reveal the mechanisms of Yu-Ye Tang on type 2 diabetes mellitus rats.

Not available

S-EPMC10507721 | biostudies-literature

UPLC-QTOF-MS-Based Plasma Lipidomic Profiling Reveals Biomarkers for Inflammatory Bowel Disease Diagnosis

Identification of new biomarkers may help in the early diagnosis of inflammatory bowel disease (IBD). In this study, ultrahigh-performance liquid chromatography equipped with quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS) was used to analyze the untargeted lipidomics and compare plasma l...

2021-10-18 | MTBLS1183 | MetaboLights

Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial.

Not available

S-EPMC8495912 | biostudies-literature

Integrated multi-omics reveals the Bacillus amyloliquefaciens BA40 against Clostridium perfringens infection in weaned piglets.

Not available

S-EPMC12627879 | biostudies-literature

Effects of Kami Guibi-tang in patients with mild cognitive impairment: study protocol for a phase III, randomized, double-blind, and placebo-controlled trial.

Not available

S-EPMC9717542 | biostudies-literature

Efficacy of Kami Guibi-tang as an Add-On Therapy to Acetylcholinesterase Inhibitor for Cognitive Function in Mild Alzheimer's Disease: A Pilot Study.

Not available